Multifunctional roles for MALT1 in T-cell activation

Nature Reviews Immunology

Volumn 8, Issue 7, 2008, Pages 495-500

  Thome, Margot ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; FC RECEPTOR; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MALT1 PROTEIN; PROTEIN; PROTEIN BCL 10; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME;

AUTOIMMUNITY; B CELL LYMPHOMA; BINDING SITE; ENZYME PHOSPHORYLATION; GRAFT REJECTION; HUMAN; IMMUNOMODULATION; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CASPASES; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOMA, B-CELL; MICE; NEOPLASM PROTEINS; NF-KAPPA B; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 46249085882     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2338     Document Type: Review

References (43)

1. Ruland, J., Duncan, G. S., Wakeham, A. & Mak, T. W. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 19, 749-758 (2003).
2. Ruefli-Brasse, A. A., French, D. M. & Dixit, V. M. Regulation of NF-κB-dependent lymphocyte activation and development by paracaspase. Science 302, 1581-1584 (2003).
3. Wegener, E. & Krappmann, D. CARD-Bcl10-Malt1 signalosomes: missing link to NF-κB. Sci. STKE 2007, pe21 (2007).
4. Ruland, J. et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104, 33-42 (2001).
5. Uren, A. G. et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6, 961-967 (2000).
6. Lucas, P. C. et al. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-κB signaling pathway. J. Biol. Chem. 276, 19012-19019 (2001).
7. Ferch, U. et al. MALT1 directs B cell receptor-induced canonical nuclear factor-κB signaling selectively to the c-Rel subunit. Nature Immunol. 8, 984-991 (2007).
8. Akagi, T. et al. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 18, 5785-5794 (1999).
9. Dierlamm, J. et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93, 3601-3609 (1999).
10. Morgan, J. A. et al. Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res. 59, 6205-6213 (1999).
11. Isaacson, P. G. & Du, M. Q. MALT lymphoma: from morphology to molecules. Nature Rev. Cancer 4, 644-653 (2004).
12. Lucas, P. C., McAllister-Lucas, L. M. & Nunez, G. NF-κB signaling in lymphocytes: a new cast of characters. J. Cell. Sci. 117, 31-39 (2004).
13. Ngo, V. N. et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441, 106-110 (2006).
14. Jost, P., Peschel, C. & Ruland, J. The Bcl10/Malt1 signaling pathway as a drug target in lymphoma. Curr. Drug Targets 7, 1335-1340 (2006).
15. Thome, M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nature Rev. Immunol. 4, 348-359 (2004).
16. Gross, O. et al. Multiple ITAM-coupled NK cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-κB and MAPK activation to selectively control cytokine production. Blood 11 January 2008 (doi:10.1182/blood-2007-11-123513).
17. Gross, O. et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442, 651-656 (2006).
18. Hara, H. et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nature Immunol. 8, 619-629 (2007).
19. Klemm, S. et al. The Bcl10-Malt1 complex segregates FcεRI-mediated nuclear factor κB activation and cytokine production from mast cell degranulation. J. Exp. Med. 203, 337-347 (2006).
20. Dong, W. et al. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-κB from Toll-like receptor 4. J. Biol. Chem. 281, 26029-26040 (2006).
21. Hsu, Y.-M. S. et al. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nature Immunol. 8, 198-205 (2007).
22. Uren, A. G. et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6, 961-967 (2000).
23. Rawlings, D. J., Sommer, K. & Moreno-García, M. E. The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nature Rev. Immunol. 6, 799-812 (2006).
24. Hacker, H. & Karin, M. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006, re13 (2006).
25. Zhou, H., Du, M. Q. & Dixit, V. M. Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 7, 425-431 (2005).
26. Che, T. et al. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κB activation. J. Biol. Chem. 279, 15870-15876 (2004).
27. Sun, L., Deng, L., Ea, C. K., Xia, Z. P. & Chen, Z. J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289-301 (2004).
28. Noels, H. et al. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-κB activation by API2-MALT1 fusions. J. Biol. Chem. 282, 10180-10189 (2007).
29. Yoneda, T. et al. Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein. J. Biol. Chem. 275, 11114-11120 (2000).
30. Oeckinghaus, A. et al. Malt1 ubiquitination triggers NF-κB signaling upon T-cell activation. EMBO J. 26, 4634-4645 (2007).
31. Wu, C. J. & Ashwell, J. D. NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-κB activation. Proc. Natl Acad. Sci. USA 105, 3023-3028 (2008).
32. Stilo, R. et al. Physical and functional interaction of CARMA1 and CARMA3 with Iκkinaseγ-NFκB essential modulator. J. Biol. Chem. 279, 34323-34331 (2004).
33. Shambharkar, P. B. et al. Phosphorylation and ubiquitination of the IκB kinase complex by two distinct signaling pathways. EMBO J. 26, 1794-1805 (2007).
34. Snipas, S. J. et al. Characteristics of the caspase-like catalytic domain of human paracaspase. Biol. Chem. 385, 1093-1098 (2004).
35. Coornaert, B. et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-κB inhibitor A20. Nature Immunol. 9, 263-271 (2008).
36. Rebeaud, F. et al. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nature Immunol. 9, 272-281 (2008).
37. Vercammen, D., Declercq, W., Vandenabeele, P. & Van Breusegem, F. Are metacaspases caspases? J. Cell Biol. 179, 375-380 (2007).
38. Heyninck, K. & Beyaert, R. A20 inhibits NF-κB activation by dual ubiquitin-editing functions. Trends Bioch. Sci. 30, 1-4 (2005).
39. Klinkenberg, M., Van Huffel, S., Heyninck, K. & Beyaert, R. Functional redundancy of the zinc fingers of A20 for inhibition of NF-κB activation and protein-protein interactions. FEBS Lett. 498, 93-97 (2001).
40. Kinashi, T. Intracellular signalling controlling integrin activation in lymphocytes. Nature Rev. Immunol. 5, 546-559 (2005).
41. Lu, T. T. & Cyster, J. G. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297, 409-412 (2002).
42. Rueda, D. et al. Bcl10 controls TCR- and FcγR-induced actin polymerization. J. Immunol. 178, 4373-4384 (2007).
43. Zhou, H. et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO. Nature 427, 167-171 (2004).